Product Reports Resources Pricing Login Book a demo

Doctolib

Health Tech & Medtech · Levallois-Perret, France · Founded 2013

Transforming healthcare through technology

Investors

12 investors on Doctolib's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 4 investors entered at this stage
Olivier Occelli
Agoranov
Kerala Ventures
Bertrand Jelensperger
Series A 1 investor entered at this stage
Pierre Kosciusko-Morizet
Series B+ 7 investors entered at this stage
Ludwig Klitzsch
Bpifrance
General Atlantic
Eurazeo
Accel
Kernel
Nicolas Brusson

Ownership

Who owns Doctolib

Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (Jan/2026). Percentages are indicative.

28.5% Founders
  • Eurazeo 13.5%

Some investors are hidden on this public profile. See the full cap table on Dealroom →

Global footprint

Where Doctolib has talent and traffic

Workforce by country
24 countries with
team presence
🇫🇷 France62.3%
🇩🇪 Germany25.4%
🇮🇹 Italy9.9%
🇳🇱 Netherlands0.9%
🇨🇭 Switzerland0.3%
Top 5 of 24 shown
Web traffic by country
36M monthly visits
across markets
🇫🇷 France98.6%
🇺🇸 United States0.4%
🇧🇪 Belgium0.4%
🇩🇪 Germany0.2%
🇨🇭 Switzerland0.2%
Top 5 markets shown

Talent graph

The shape of Doctolib's talent

Dealroom maps Doctolib's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

27 standout operatorsDealroom-flagged across the org
92 AI specialistsincl. 21 core researchers
3,699 employees mappedperson by person
DimensionScore
AI Talentlive Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Doctolib's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Capital deployed

Doctolib's 7 investments and acquisitions.

Every disclosed deal where Doctolib appeared as a backer or acquirer, 2016–2024. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

7 deals across Doctolib's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        Doctolib's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        7 of 7 deals

        Market sentiment

        What the market is saying about Doctolib

        An AI-synthesized read of the highest-engagement posts about Doctolib on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Doctolib on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.